Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT06930625

A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

Led by Debiopharm International SA · Updated on 2026-04-28

119

Participants Needed

71

Research Sites

170 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary purpose of this study is to assess the effect of Debio 4126 in the maintenance of the levels of insulin-like growth factor 1 (IGF-1) ≤1x upper limit of normal (ULN) in the double-blind period (Period 1) in comparison to placebo at week 36.

CONDITIONS

Official Title

A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients 18 years of age or older
  • Receiving octreotide or lanreotide monotherapy for acromegaly for at least 6 months at a stable dose for the last 12 weeks
  • IGF-1 at screening at or below 1x upper limit of normal
  • Diagnosed with acromegaly as defined by the study protocol
  • Adequate bone marrow, liver, and kidney function
  • For entry into Period 2: IGF-1 at or below 1x upper limit of normal at Week 34, or up to Week 48 if treated with rescue medication
  • Other criteria defined by the protocol
Not Eligible

You will not qualify if you...

  • Compression of optic chiasm causing visual defects
  • Symptomatic gallstones or bile duct dilation
  • Planned gallbladder removal during the trial
  • Acute or chronic pancreatitis
  • Previous pituitary radiotherapy
  • Uncontrolled hypothyroidism
  • Uncontrolled diabetes
  • Pituitary surgery within 6 months before screening or planned during the trial
  • Treatment with pasireotide within 6 months prior to screening, or pegvisomant or dopamine agonists within 3 months prior
  • Recent or ongoing cardiovascular or thromboembolic diseases including heart failure, heart attack, stroke, certain arrhythmias, and pulmonary embolism
  • Other criteria defined by the protocol

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 71 locations

1

Cedars Sinai Medical Center

Los Angeles, California, United States, 90048

Actively Recruiting

2

Northwestern University

Chicago, Illinois, United States, 60611

Actively Recruiting

3

Harvard Medical School

Boston, Massachusetts, United States, 01952

Actively Recruiting

4

Washington University-School of Medicine

St Louis, Missouri, United States, 63110

Actively Recruiting

5

Palm Research Center Inc

Las Vegas, Nevada, United States, 89128

Actively Recruiting

6

The Cleveland Clinic

Cleveland, Ohio, United States, 44195

Actively Recruiting

7

The Ohio State University

Columbus, Ohio, United States, 43210

Actively Recruiting

8

Oregon Health & Science University

Portland, Oregon, United States, 97239

Actively Recruiting

9

Thomas Jefferson University

Philadelphia, Pennsylvania, United States, 19107

Actively Recruiting

10

Medical University Graz

Graz, Austria, A-8036

Actively Recruiting

11

Medizinische Universitaet Wien - Division of Endocrinology and Metabolism

Vienna, Austria, 1090

Actively Recruiting

12

UZ Gent

Ghent, Belgium, 9000

Actively Recruiting

13

CETI - Centro de Estudos em Terapias Inovadoras

Curitiba, Brazil, 80030-110

Actively Recruiting

14

Nucleo de Pesquisa e Desenvolvimento de Medicamentos (NPDM)

Fortaleza, Brazil, 60430-275

Actively Recruiting

15

Hospital das Clinicas da UFMG

Minas Gerais, Brazil, 30130-100

Not Yet Recruiting

16

Instituto Estadual do Cérebro Paulo Niemeyer (IECPN)

Rio de Janeiro, Brazil, 20231-092

Actively Recruiting

17

Hospital das Clinicas - University of Sao Paulo Medical School

São Paulo, Brazil, 5403000

Actively Recruiting

18

University Specialized Hospital for Active Treatment of Endocrinology Akad. lv Penchev EAD

Sofia, Bulgaria, 1431

Actively Recruiting

19

Rigshospitalet, Blegdamsvej 9

Copenhagen, Denmark, DK-2100

Actively Recruiting

20

Zealand University Hospital

Køge, Denmark, 4600

Actively Recruiting

21

East Tallinn Central Hospital

Tallinn, Estonia, 10138

Actively Recruiting

22

North Estonia Medical Centre Foundation

Tallinn, Estonia, 13419

Actively Recruiting

23

CHU d'Angers

Angers, France, 49933

Actively Recruiting

24

Hospices Civils de Lyon

Bron, France, 69677

Actively Recruiting

25

APHP - Hôpital Bicêtre

Le Kremlin-Bicêtre, France, 94275

Actively Recruiting

26

Assistance Publique Hopitaux de Marseille (AP-HM) - Hopital La Conception

Marseille, France, 13005

Actively Recruiting

27

Hopital Haut-Leveque

Pessac, France, 33600

Actively Recruiting

28

CHU Toulouse - Hôpital Larrey

Toulouse, France, 31059

Actively Recruiting

29

Charité Universitätsmedizin Berlin

Berlin, Germany, 10117

Actively Recruiting

30

Klinikum der Universität München Medizinische Klinik und Poliklinik IV - Zi

Munich, Germany, 80336

Actively Recruiting

31

Universitätsklinikum Würzburg - Poliklinik I - Endokrinologie u. Diabetolog

Würzburg, Germany, 97080

Actively Recruiting

32

Semmelweis Egyetem, Belgyogyaszati es Onkologiai Klinika

Budapest, Hungary, 1083

Actively Recruiting

33

Eszak-Pesti Centrumkorhaz-Honvedkorhaz Endokrinologia

Budapest, Hungary, 1134

Actively Recruiting

34

University of Szeged Faculty of Medicine

Szeged, Hungary, 6725

Actively Recruiting

35

Bnai Zion Medical Center

Haifa, Israel, 3104802

Actively Recruiting

36

Rambam Health Care Campus

Haifa, Israel, 3109601

Actively Recruiting

37

Rabin Medical Center - Beilinson Campus

Petah Tikva, Israel, 49100

Actively Recruiting

38

Tel Aviv Sourasky Medical Center

Tel Aviv, Israel, 64239

Actively Recruiting

39

Azienda ospedaliero Universitaria di Ferrara

Ferrara, Italy, 44124

Actively Recruiting

40

Ospedale Policlinico San Martino IRCCS

Genova, Italy, 16132

Actively Recruiting

41

ASST Grande Ospedale Metropolitano Niguarda

Milan, Italy, 20162

Actively Recruiting

42

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano

Milan, Italy, 20122

Actively Recruiting

43

IRCCS Ospedale San Raffaele

Milan, Italy, 20132

Actively Recruiting

44

AOU Federico II Napoli

Naples, Italy, 80131

Not Yet Recruiting

45

Azienda Ospedale Università di Padova

Padova, Italy, 35124

Actively Recruiting

46

Fondazione Policlinico Universitario A Gemelli

Roma, Italy, 00168

Actively Recruiting

47

University of Torino

Torino, Italy, 10126

Actively Recruiting

48

Pauls Stradins Clinical University Hospital

Riga, Latvia, LV-1002

Actively Recruiting

49

Lithuanian Health Science University Hospital Kauno klinikos

Kaunas, Lithuania, LT-50161

Actively Recruiting

50

Vaidotas Urbanavicius Sole Proprietor Enterprise

Vilnius, Lithuania, LT-09112

Actively Recruiting

51

Centrum Medyczne Intercor Sp. z o.o.

Bydgoszcz, Poland, 85-605

Actively Recruiting

52

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie

Gliwice, Poland, 44-101

Actively Recruiting

53

Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences

Poznan, Poland, 60-355

Actively Recruiting

54

Uniwersytecki Szpital Kliniczny we Wroclawiu

Wroclaw, Poland, 52-007

Actively Recruiting

55

Institutul National de Endocrinologie "C.I. Parhon"

Bucharest, Romania, 011863

Actively Recruiting

56

Delta Health Care

Bucharest, Romania, 014142

Actively Recruiting

57

Spitalul Clinic Judetean de Urgenta Cluj-Napoca

Cluj-Napoca, Romania, 400347

Actively Recruiting

58

University Clinical Center of Serbia

Belgrade, Serbia, 11000

Actively Recruiting

59

University Clinical Center of Serbia

Belgrade, Serbia, 11000

Not Yet Recruiting

60

Narodni endokrinologicky a diabetologicky ustav

Ľubochňa, Slovakia, 03491

Actively Recruiting

61

Hosiptal Universitario de la Ribera

Alzira, Spain, 46600

Actively Recruiting

62

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain, 08025

Actively Recruiting

63

Hospital Universitario Vall d'Hebron

Barcelona, Spain, 08035

Actively Recruiting

64

Hospital Universitario Germans Trias i Pujol

Barcelona, Spain, 08916

Actively Recruiting

65

Hospital Ramón y Cajal

Madrid, Spain, 28034

Actively Recruiting

66

Complexo Hospitalario Universitario de Santiago de Compostela

Santiago de Compostela, Spain, 15705

Actively Recruiting

67

Hospital Universitario Virgen del Rocio

Seville, Spain, 41013

Actively Recruiting

68

Karolinska University Hospital

Stockholm, Sweden, 17176

Actively Recruiting

69

Uppsala University Hospital

Uppsala, Sweden, 751 85

Actively Recruiting

70

University Hospitals Birmingham NHS Foundation Trust

Birmingham, United Kingdom, B15 2GW

Actively Recruiting

71

Leeds Teaching Hospitals NHS Trust

Leeds, United Kingdom, LS9 7TF

Actively Recruiting

Loading map...

Research Team

D

Debiopharm International S.A

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs | DecenTrialz